Preoperative Chemotherapy
Preoperative Chemotherapy - Related Videos
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
0 Views •
Cited by 28 •
2012
This abstract describes a novel method to assess the development of neurotoxicity in patients receiving chemotherapy treatment. While conventional assessment methods are limited in their ability to detect early changes in nerve function, nerve excitability techniques provide early identification of patients at risk of severe neurotoxicity and insight into pathophysiology.
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
0 Views •
Cited by 15 •
2016
The current report summarizes a protocol that can be utilized to model the influence of the bone marrow microenvironment niche on leukemic cells with emphasis placed on enrichment of the most chemoresistant subpopulation.
01:16
Preoperational Thought IV: Numbers
0 Views •
2026
Piaget’s preoperational stage, from about ages 2 to 7, is characterized by rapid growth in symbolic thinking. Children increasingly use words, images, and objects to represent ideas, although their reasoning remains largely intuitive. During this period, number sense develops from memorized counting toward an understanding of quantity and basic arithmetic.Counting and CardinalityChildren younger than age 3 may recite number words without fully understanding their numerical meaning. During the...
01:19
Preoperational Thought I: The Symbolic Function
0 Views •
2026
Jean Piaget’s preoperational stage of cognitive development spans approximately ages 2 to 7. During this period, children increasingly think symbolically but are not yet able to perform logical mental operations consistently. Symbols are words, pictures, numbers, or objects that stand for something else. For example, the word "dog" can represent an entire category of animals, even when no dog is physically present. This ability allows children to mentally represent people, objects, and events...
01:30
Conservation During the Preoperational Stage
0 Views •
2026
Conservation is the understanding that quantity remains unchanged when appearance or arrangement changes, provided nothing is added or removed. Piaget used conservation tasks to examine children’s developing logical reasoning and their tendency to rely on perceptual appearance.Liquid Conservation TaskIn the classic liquid conservation task, a child is shown equal amounts of water in two identical short, wide glasses. The water from one glass is then poured into a taller, narrower glass. Many...
FAQs
Its systemic anticancer drugs can affect both the visible primary tumor and microscopic cancer cells elsewhere in the body. By disrupting DNA replication and cell division, they may reduce the amount of disease present before local treatment begins. This dual reach explains why the approach can address risks that surgery focused only on the primary site may not address.
Tumor response before surgery provides an early treatment signal. Shrinkage may indicate that the selected regimen is affecting the cancer, whereas limited response supplies information for planning subsequent therapy. This makes response assessment more than a measurement of size: it can help connect the initial systemic treatment with decisions about what follows.
The balance of benefit and risk depends on the cancer type, its stage, the drug regimen, and the patient’s overall health. These variables influence how suitable the approach may be and how its effects should be interpreted. Consequently, the same treatment strategy may have different implications across patients or disease settings.
The sequence begins with systemic drug treatment before surgery or another local treatment. During this period, the tumor’s response can provide early information, including whether disease burden is changing. That information can then help guide subsequent therapy and the effectiveness or feasibility of the planned local treatment.
Reducing tumor burden before local treatment can make an initially difficult tumor more amenable to resection. The relevant outcome is not only whether the tumor becomes smaller, but whether its reduced burden improves the practicality of removing it. This application connects systemic treatment with the goal of achieving more effective local control.
Its role must be considered in relation to disease characteristics and patient condition rather than applied uniformly. Cancer type and stage help define the clinical setting, while regimen choice and overall health affect the expected balance of benefit and risk. Early response information can further guide what treatment should follow the initial course.